
Opinion|Videos|November 26, 2024
The Role of Testing for C Difficile in Clinical Practice
Author(s)Paul Feuerstadt, MD, FACG, AGAF
Key Takeaways
- Testing for C. difficile is indicated in patients with diarrhea, especially after antibiotic use or healthcare exposure.
- Early testing facilitates prompt diagnosis and management, influencing treatment initiation timing.
Paul Feuerstadt, MD, FACG, AGAF, discusses how testing for Clostridioides difficile is recommended for hospitalized patients or outpatients with new-onset, unexplained diarrhea who have risk factors such as recent antibiotic use, hospitalization, or older age, and how empiric treatment should be initiated while awaiting test results if there is high clinical suspension.
Advertisement
Episodes in this series

Now Playing
Video content above is prompted by the following:
- In which patients do you test for C difficile before treating?
- Does the timing of the testing influence when you start treatment?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
2
Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD
3
Elinzanetant Shows Strong 52-Week Safety for Vasomotor Symptoms: James Simon, MD
4
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
5

















































